There's intense focus on EPAM Systems Inc. as the company's stock experienced several shifts recently, accompanied by mixed views from analysts. TD Cowen upgraded the company from Hold to Buy, driven by anticipation of a recovery growth, leading to a 10.9% surge following the firm's upgraded 2025 view due to robust AI demand. The company also launched DIAL 3.0, an evolution of its open-source GenAI Enterprise Platform, along with securing a multi-year deal with the States of Guernsey.
Significant Q2 results encouraged the company's decision to elevate its full-year revenue outlook. However, JPMorgan decreased the price target from $205 to $201. Nevertheless, Stifel Nicolaus maintains its Buy rating with a price target of $246.
The IT giant has expanded its operations to Azerbaijan in its ongoing mission for digital transformation and building AI-native services.
The company also stands out for its investment in AI training for opportunities in the healthcare sector and maintaining strategic hiring to strengthen its presence in India. The company recently announced a change in leadership, with incoming CEO Balazs Fejes steering its future path.
Epam Systems EPAM News Analytics from Wed, 05 Feb 2025 08:00:00 GMT to Sun, 24 Aug 2025 00:28:38 GMT - Rating 7 - Innovation 7 - Information 8 - Rumor 4
